Menu Back toSESSION-3-TECHNICAL-ISSUES

Clinical Trial Regulation Conference

This conference provides a forum for information exchange and discussion on conceptual and practical questions about critical issues affecting sponsors and Member States regarding the implemention the regulation.


SESSION 3: TECHNICAL ISSUES

Session Chair(s)

Judith  Creba, PhD

Judith Creba, PhD

  • Executive Director, EU Regulatory Strategy
  • Novartis Pharma AG, Switzerland

Speaker(s)

Sini  Eskola, MPharm, MSc

Annex VI: Discussion of the Key Issues and How to Address Them

Sini Eskola, MPharm, MSc

  • Director Regulatory Affairs
  • European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Isabelle  Clamou

Implementation Guidance and Delegated Acts - Awareness of and the Key Identified Issues from the Draft Guidance

Isabelle Clamou

  • Regulatory affairs Director - EU Policy
  • Amgen Ltd, Belgium
Maja  Leon-Grzymkowska

Maja Leon-Grzymkowska

  • Legal Officer at European Commission
  • European Commission, Belgium

Contact us

 Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics Questions

Send Email
+41 61 225 51 49